Interpace Biosciences is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.
Interpace Biosciences is a publicly traded company on NCM using the ticker symbol IDXG.
Detailed information on company financials and operating reports can be found here:
NCM: IDXG
Interpace Biosciences Annual Revenue and Growth Rate
Note: Interpace Biosciences's revenues are gauged from an analysis of company filings.
Investor Activity
Interpace Biosciences has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
January 27, 2020
2
100%
$47 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Interpace Biosciences is developing and marketing.
Interpace Biosciences doesn't have any recent trademark applications, indicating Interpace Biosciences is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
POINT2 Human biomedical diagnostic testing services to aid in the diagnosis and resolution of disease
04/12/2022
SPATIALPLEX Scientific and technological services, namely, imaging and morphologically-guided investigation of human and animal tissues, investigating and interpreting biomarkers including DNA, RNA, amino acids, miRNA, epigenetic and biological data, all for the purpose of developing medical therapies
06/04/2021
WE OWN OUR FUTURE Laboratory services for pharmaceutical development and medical research and molecular tests that aid in the diagnosis and resolution of disease
02/22/2021
See all trademarks and details in the Full Report.
Market Share of Interpace Biosciences's Largest Competitors
A competitive analysis shows these companies are in the same general field as Interpace Biosciences, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Interpace Biosciences.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Interpace Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.